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1. Introduction
cstasy or 3, 4- methylenedioxymetham-
phetamine (MDMA) is a synthetic amphet-
amine analog used as a recreational drug. 
MDMA causes heightened sense of empa-
thy, feeling of closeness toward others, and 
elevated mood (Farre et al., 2004). It can produce a set 
of behaviors referred to serotonin behavioral syndrome 
(Lyles & Cadet, 2003). It has been reported that MDMA 
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Introduction: Exposure to 3, 4- methylenedioxymethamphetamine (MDMA) could lead to 
serotonergic system toxicity in the brain. This system is responsible for learning and memory 
functions. Studies show that MDMA causes memory impairment dose-dependently and 
acutely. The present study was designed to evaluate the chronic and acute effects of MDMD 
on spatial memory and acquisition of passive avoidance.  
Methods: Adult male Wistar rats (200-250 g) were given single or multiple injections of 
MDMA (10 mg/kg, IP). Using passive avoidance and Morris Water Maze (MWM) tasks, 
learning and spatial memory functions were assessed. The data were analyzed by SPSS 16 
software and one- way analysis of variance (ANOVA) test. 
Results: Our results showed that there were significant differences in latency to enter the dark 
compartment (STL) between sham and MDMA- treated groups. Acute group significantly 
showed more STL in comparison with chronic group. Furthermore, MDMA groups spent 
more time in dark compartment (TDS) than the sham group. Administration of single dose 
of MDMA significantly caused an increase in TDS compared with the chronic group. In the 
MWM, MDMA treatment significantly increased the traveled distance and escaped latency 
compared to the sham group. Like to passive avoidance task, percentage of time spent in the 
target quadrant in MDMA- treated animals impaired in MWM compared with sham group.
Discussion: These data suggest that MDMA treatment impairs learning and memory functions 
that are more extensive in acute- treated rats.  
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has neurotoxic effects on serotonergic, dopaminergic, 
and adrenergic endings with highest affinity to seroto-
nergic transporter (SERT), and 5- hydroxytryptamine 2 
(5-HT2)  receptor (Sarkar & Schmued, 2010). MDMA 
causes acute release of serotonin from nerve endings, 
binds to the SERT, and inhibits serotonin reuptake (Si-
mantov, 2004) . MDMA administration was found to 
decrease serotonin in the prefrontal cortex, neostriatum, 
and hippocampus, which are important structures in 
learning and spatial memory functions (Able, Gudelsky, 
Vorhees, & Williams, 2006; Kalechstein, De La Garza II, 
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Mahoney III, Fantegrossi, & Newton, 2007). Several ev-
idences show that central executive and decision- mak-
ing skills alter in persistent MDMA users (Bolla, Mc-
Cann, & Ricaurte, 1998; J. E. Sprague, Preston, Leifheit, 
& Woodside, 2003; Zakzanis & Campbell, 2006).
It has been shown that MDMA treatment causes pro-
duction of  hydroxyl radicals and lipid peroxidation and 
induces serotonergic neurotoxicity (J. Sprague, Ever-
man, & Nichols, 1998). Serotonin has a modulatory ef-
fect on long-term potentiation (LTP) in the hippocampus 
(Slivka, Mytilineou, & Cohen, 1987).
Previous studies reported that MDMA treatment lead 
to decrease of novel object recognition and anxiety in 
the elevated plus maze (Piper, Fraiman, & Meyer, 2005). 
Furthermore, different doses of MDMA impaired loco-
motor activity and allocentric learning dose-dependently 
and acutely in rats (Vorhees et al., 2009). Several stud-
ies reported acute effect of single or multiple doses of 
MDMA on the learning and spatial memory functions 
(Asi et al., 2011; Soleimani Asl et al., 2011; Vorhees, 
Reed, Skelton, & Williams, 2004) , but no study have 
examined the chronic effects of MDMA on the memory. 
There are some tasks to evaluate learning and memory 
functions. The Passive avoidance learning is believed 
to be based on the contextual memory, which is asso-
ciated with the place and the event of "being given the 
electric shock in the dark box". The hippocampus plays 
an important role in the contextual memory; injuries of 
the hippocampus decrease the performance of passive 
avoidance learning (Hirsh, 1974).
The Morris water navigation task, also known as the 
Morris water maze, is a behavioral procedure widely 
used to study  learning and spatial memory function. The 
key brain regions involved in navigation in the Morris 
water maze task include the striatum, the frontal cortex, 
and especially the hippocampus (R. G. M. Morris, P. 
Garrud, J. N. P. Rawlins, & J. O'Keefe, 1982).
Because MDMA treatment lead to toxicity of hippo-
campus and it involves in navigation of the MWM and 
passive avoidance tasks, the aims of this study were to 
evaluate the acute and chronic effects of MDMA on 
learning and spatial memory in the passive avoidance 
and MWM tasks. 
 2. Methods
MDMA was obtained from the Presidency Drug Con-
trol Headquarters (Tehran, Iran), and the solutions were 
made in sterile saline at a specific concentration.
2.1. Animals
Twenty eight male Wistar rats, aged 8-11 months, 
weighting 200-250 g, were obtained from the Iranian 
Pasteur Institute, Tehran, Iran. Before any treatment, the 
rats were allowed to acclimatize to the colony room for 1 
week. The rats were kept in colony room at a temperature 
of 21 ± 1°C (50 ± 10% humidity) at a 12-hour light-dark 
cycle with access to water and food ad libitum. Then, the 
rats were randomly classified into four MDMA-treated 
and sham groups (n=7 per group) as followed: 
1. Acute sham saline group received intraperitoneal 
(IP) injection of 1 mls normal saline for once.
2. Chronic sham saline group received IP injections of 
1 mls normal saline in the weekend for three weeks (1, 
2, 8, 9, 15, 16 days).
3. Acute MDMA group received IP injection of 10 mg/
kg MDMA for once.
4. Chronic sham saline group received IP injections of 
10mg/kg MDMA in the weekend for three weeks (1, 
2, 8, 9, 15, 16 days). The day after last administration, 
memory was assessed using shuttle box and MWM.
2.2. Inhibitory Avoidance Apparatus (Shuttle box) 
Step-through inhibitory avoidance apparatus consisted 
of two boxes of the same size (20 × 20 × 30 cm). There 
was a guillotine door in the middle of a dividing wall. 
The walls and floor of one compartment consisted of 
white opaque resin and the walls of the other one was 
dark. Intermit-tent electric shocks (50 Hz, 3 s, 1.5 mA 
intensity) were delivered to the grid floor of the dark 
compartment by an isolate stimulator.
All animals were allowed to habituate in the experimen-
tal room for at least 30 min before the experiments. Then, 
each animal was gently placed in the white compartment 
and after 5 s the guillotine door was opened and the animal 
was allowed to enter the dark module (Azami et al., 2010). 
Animals that waited more than 300 s to enter the dark 
chamber were excluded from the experiment. Once the 
animal entered with all four paws to the next chamber, 
the guillotine door was closed and the rat was immedi-
ately withdrawn from the compartment. This trial was 
repeated after 30 min. As in the acquisition trial, when 
the animal entered the dark (shock) compartment, the 
door was closed; and a foot shock (50 Hz, 1 mA and3 s) 
was immediately delivered to the grid floor of the dark 
room. After 20 s, the rat was removed from the apparatus 
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and placed temporarily into its home cage. Two minutes 
later, the animal was retested in the same way as in the 
previous trials; if the rat did not enter the dark compart-
ment during 300 s, a successful acquisition of inhibitory 
avoidance response was recorded. Otherwise, when the 
rat entered the dark compartment (before 300 s) a sec-
ond time, the door was closed and the animal received 
the shock again. After retesting, if the rat learned inhibi-
tory avoidance response successfully, it was moved to the 
cage and received MDMA or saline. On the retention trail 
(24 h after drug administration), each animal was gently 
placed in the light compartment and after 5 s the door was 
opened and the latency which the animal entered the dark 
chamber (STL) and the total time spent in dark compart-
ment (TDS) were recorded in the absence of electric foot 
shocks, as indicator of inhibitory avoidance behavior.
2.3. Morris Water Maze Performance
A Morris water maze apparatus, consisted of a circu-
lar pool (180 cm in diameter, 60 cm in height), painted 
black, filled to a depth of 25 cm with water 22 ± 1°C, 
was used for assessing spatial memory (Asi et al., 2011).
The pool was divided into four quadrants with four 
starting locations, referred to as north (N), east (E), 
south (S) and west (W) and an invisible Plexiglass 
platform (10 cm diameter) was located 1 cm below the 
water in the center of northern quadrant. The animals 
were trained for 3 days at approximately the same time 
(10:00-12:00 a.m.) each day that included two block-
swith four trials (90 seconds). Between two trials, the 
animals spent 30 seconds on the platform. The rats were 
allowed to rest for 5 minutes between two consecutive 
blocks. A video camera (Nikon, Melville, New York, 
USA) linked to a computer was mounted directly above 
the water maze pool to record the time taken to reach 
the hidden platform (the escape latency), the length of 
swim path (the traveled distances) and the percentage of 
spent time in target quadrant for each rat. The day after 
the last learning trial, each rat was given a single 60-sec-
ond probe trial (retention trail) and visible test. In probe 
trials, no platform was present. In the visible trials, the 
platform was covered with aluminum foil. 
2.4. Statistical Analysis
The data were expressed as mean ± S.E.M and ana-
lyzed by SPSS 16 software. The statistical analyses 
were performed using one way analysis of variance 
(ANOVA) and Post-hoc comparison of means was car-
ried out with the Tukey test (t-test) for multiple com-
parisons, when appropriate. The value of p<0.05 was 
considered significant. 
3. Results
As there were no differences between acute and chronic 
sham saline groups, herein, we reported only one sham group.
3.1. Passive Avoidance Task
In the acquisition trial, we found no difference between 
the sham and MDMA groups in the STL and TDC (data 
not shown). However, the injection of MDMA reduced 
the STL in the retention trial compared to the sham 
groups (p<0.001, Figure 1A). 
Furthermore, MDMA- treated rats spent more time 
in the dark compartment (TDC) compared to the sham 
group (p<0.001, Figure 1B). Furthermore, there was sig-
nificant difference between chronic and acute groups in 
the TDS (p<0.001, Figure 1B).
Figure 1. Effects of MDMA treatment on passive avoidance performance. The mean of the step- through latency to 
enter to the dark compartment (A), (a p<0.001 vs. sham group) and the time spent in dark compartment (B), (a p<0.001 
vs. sham group, b p<0.001 vs. acute group). The values were presented as mean ± S.E.M.
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3.2. Morris Water Maze performance
The results from MWM showed that MDMA increases 
the escape of latency to find hidden platform.
Analysis of variance of three training days showed that 
MDMA treatment significantly increased the escape of 
latency compared with sham group (p<0.001 for acute 
group, p<0.05 for chronic group, Figure 2A). Further-
more, there was significant difference between acute 
and chronic MDMA groups (p< 0.01, Figure 2A) and 
MDMA acutely showed exaggerated response. 
As shown in figure 2B, MDMA- treated rats spent 
more distance to reach to hidden platform that were 
significant compared with sham group ( p< 0.001 for 
acute group, p<0.01  for chronic group). According 
to the results, acute administration of MDMA signifi-
cantly increased the traveled distance in comparison 
with the chronic- treated MDMA group (p<0.001, 
Figure 2A). 
The analysis of variance of our results showed 
that sham group spent more time in target quadrant 
that was significant compared with MDMA groups 
(p<0.001 for acute group, p<0.01 for chronic group, 
Figure 2C).  Acutely- treated rats insignificantly spent 
less time in target quadrant in comparison with chron-
ic- treated rats. 
4. Discussion
The results of this study showed that MDMA led to 
memory impairment in MWM and passive avoidance 
tasks. The other finding was that the MDMA- induced 
memory impairment in the acute- treated rats was more 
exaggerated than the chronic- treated rats. It was re-
ported that MDMA treatment in rats on postnatal day 
11 induced spatial and references memory impairment 
(Vorhees et al., 2004). In another study, non- acute ex-
posure to MDMA caused memory impairment dose-
dependently (Asi et al., 2011). Consistent to our results, 
Sprague et al. showed that MDMA treatment resulted 
in reduction of preference for the target quadrant in the 
Figure 2. Effects of MDMA on spatial memory in MWM. MDMA increased the escape latency (a p<0.001 vs. sham group, b p< 
0.05 vs. sham group, C p<0.01 vs. acute group, A) and traveled distance (a p<0.001 vs. sham group, b p< 0.01 vs. sham group, C 
p<0.01 vs. acute group, B). MDMA reduced the spent time in target quarter (a p<0.001 vs. sham group, b p< 0.01 vs. sham group).
229
Basic and Clinical
Summer  2014, Volume 5, Number 3
MWM (J. E. Sprague et al., 2003). Similarly, Fukami et 
al. reported that administration of methamphetamine as an-
other amphetamine derivate caused behavioral change in 
the rats (Fukami et al., 2004). Furthermore, it was reported 
that acute MDMA administration impaired passive avoid-
ance retention in the rats (Moyano, Frechilla, & Del Rio, 
2004). It was found that acute administration of MDMA 
before the acquisition trial of a passive avoidance task im-
paired retention 24 h later (Barrionuevo, Aguirre, Del Ro, 
& Lasheras, 2000) that confirms our results. Gurtman et 
al. showed that MDMA induced a reduction in 5-HT lev-
els in the amygdala, hippocampus, and striatum that cor-
responded to increased anxiety on the elevated plus maze 
(Gurtman, Morley, Li, Hunt, & McGregor, 2002). The key 
brain regions involved in learning and memorizing in-
clude the striatum, the frontal cortex, and the hippocampus 
(Mogensen, Pedersen, Holm, & Bang, 1995; R. Morris, P. 
Garrud, J. Rawlins, & J. O'Keefe, 1982). These regions are 
susceptible to 5-HT neurotoxicity that reported following 
MDMA treatment (J. Sprague et al., 1998). Because the 
brain has low antioxidant and cell membrane lipids, it is 
sensitive to oxidative stress (Viegas et al., 2012). Oxida-
tive stress plays a role in MDMA- induced neurotoxicity 
in the brain (Yamamoto & Raudensky, 2008). Oxidative 
stress results from an imbalance between ROS and intra-
cellular antioxidant such as glutathione (GSH). GSH has 
excitatory effects on serotonergic system and serotonin 
has a modulatory effects on long term potentiation (LTP) 
in the hippocampus that is a key structure in the memory 
(Slivka et al., 1987). It has been reported that glutathione 
depletion causes spatial memory impairment (Choy, Dean, 
Berk, Bush, & van den Buuse, 2010). Therefore, it seems 
that MDMA treatment causes glutathione depletion and 
serotonin neurotoxicity that lead to memory impairment. 
In conclusion, our results showed that the acute and 
chronic administration of MDMA induced deficits in 
passive avoidance and Morris water maze tasks that 
were more exaggerated in acute- treated rats. Therefore, 
it is not possible for the brain to improve the MDMA- 
induced toxicity in the acute administration.
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